Hologic, Inc. (NASDAQ:HOLX) shares surged 7.08 percent to $20.56 in post market ... is commencing an underwritten …
Hologic Inc. HOLX is slated to report third-quarter fiscal 2017 financial ... show that Hologic is likely to beat estimates this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 …
Last week Hologic, Inc. (NASDAQ:HOLX) adopted a poison ... each of its units while Carl Icahn accelerates divestures during the review progress. Cantor Fitzgerald analyst Jeremy Feffer told Bloomberg that Hologic is “a stock that has …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HOLX at https://www.zacks.com/ap/HOLX Keywords: Hologic, Earnings …
Hologic (HOLX) reported earnings more than 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hologic Inc. HOLX reported third-quarter fiscal 2017 adjusted earnings ... Overall, the company’s reduced revenue guidance for fiscal 2017 lowers investors’ confidence in the stock. Hologic currently has a Zacks Rank #4 (Sell). Some of the …
Mr. Amy A. McBride-Wendell is on the Board of Directors at Hologic, Inc., AxoGen, Inc., Ekso Bionics Holdings, Inc. and Ekso Bionics, Inc. Mr. McBride-Wendell was previously employed as Senior VP-Strategy & Business Development by …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HOLX at https://www.zacks.com/ap/HOLX Keywords: Hologic, Earnings …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …